MT-ND6 and neoplasm: Experimental evidence in mouse models demonstrated that G13997A and 13885insC mutations in the reduced form of the nicotinamide adenine dinucleotide dehydrogenase subunit 6 (ND6) gene are associated with the transition of poor metastatic tumor cells into a highly metastatic phenotype (12).